Zamaneh Mikhak

CIK 1962453 · Chief Medical Officer · last filed 2024-07-08

Zamaneh Mikhak is a Chief Medical Officer who has filed 4 SEC Form 4 insider transactions across 1 company since 2023. The most recent filing, for TFFP, was dated Jul 8, 2024. Across all open-market trades the lifetime net is +$42.3K, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

4

Lifetime Open-Market Net

$42.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TFF Pharmaceuticals, Inc. (TFFP) Delisted Chief Medical Officer 145,184 $0.07 $9.4K $42.3K 4 2024-07-08

Recent Filings

4 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-07-08 TFF Pharmaceuticals, Inc. (TFFP) Delisted Grant (A) +10,184 $0 EDGAR
2024-04-22 TFF Pharmaceuticals, Inc. (TFFP) Delisted Grant (A) $0 EDGAR
2023-08-15 TFF Pharmaceuticals, Inc. (TFFP) Delisted Buy (P) +120,000 $30.0K EDGAR
2023-03-13 TFF Pharmaceuticals, Inc. (TFFP) Delisted Buy (P) +15,000 $12.3K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.